Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086593
Status:
COMPLETED
Last Update Posted:
2016-10-07
First Post:
2004-07-06
Brief Title:
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline